Range
14.23 - 15.05
Vol / Avg.
109.9K/134.3K
Div / Yield
-
52 Wk
13.81 - 43.92
Mkt Cap
522.2M
Payout Ratio
-
Open
14.57
P/E
-
EPS
-0.75
Shares
36M
Outstanding
36M
Total Float
21.4M
Benzinga - May 10, 2021, 4:23PM
load more
Sector: Health Care.Industry: Pharmaceuticals
Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS-0.690-0.750 -0.0600
REV2.370M1.610M-760.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Pliant Therapeutics Questions & Anwsers

Q

How do I buy Pliant Therapeutics (PLRX) stock?

A

You can purchase shares of Pliant Therapeutics (NASDAQ: PLRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Pliant Therapeutics's (PLRX) competitors?

Q

What is the target price for Pliant Therapeutics (PLRX) stock?

A

The latest price target for Pliant Therapeutics (NASDAQ: PLRX) was reported by RBC Capital on November 24, 2021. The analyst firm set a price target for 38.00 expecting PLRX to rise to within 12 months (a possible 162.25% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Pliant Therapeutics (PLRX)?

A

The stock price for Pliant Therapeutics (NASDAQ: PLRX) is $14.49 last updated Fri Nov 26 2021 18:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does Pliant Therapeutics (PLRX) pay a dividend?

A

There are no upcoming dividends for Pliant Therapeutics.

Q

When is Pliant Therapeutics (NASDAQ:PLRX) reporting earnings?

A

Pliant Therapeutics’s $Q3 earnings are confirmed for after-market on November 9, 2021.

Q

Is Pliant Therapeutics (PLRX) going to split?

A

There is no upcoming split for Pliant Therapeutics.

Q

What sector and industry does Pliant Therapeutics (PLRX) operate in?

A

Pliant Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.